ArticleFrontiers in medicine2026
Potential molecular communication of blood and synovium through ligand-receptor interactions in osteoarthritis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteoarthritis (OA) is a common degenerative joint disease resulting from the breakdown of multiple joint tissues, remains a leading cause of disability with limited therapeutic options. Synovitis is one of the reasons of OA progression, while communication between blood and synovium during disease process is still unclear. Methods: We used transcriptomic datasets from blood and synovium of healthy controls and OA patients to investigate potential molecular crosstalk between blood and synovium in OA pathogenesis through ligand-receptor pairs. Results: Ligand-receptor pair analysis revealed 129 ligands and 137 receptors differentially expressed in blood, and 108 ligands and 86 receptors in synovium. Gene ontology enrichment analysis of differentially expressed ligands indicated receptor ligand activity in both tissues, with blood enriched in leukocyte migration, cell chemotaxis, and leukocyte chemotaxis, and synovium in negative regulation of response to external stimulus, epithelial cell proliferation, and cell chemotaxis. Further protein-protein interaction (PPI) network analysis showed that blood ligands were mainly associated with inflammation and immunity (IL6, IL1B, IL23A, IFNA1, and TNF), while several synovium ligands were linked to angiogenesis (TGFB1, FGF7, and PDGFA). Based on ligand-receptor interactions and PPI network of differentially expressed ligands, we predicted and constructed molecular communication map between blood and synovium. Immunofluorescence staining of synovium showed more blood micro-vessels in OA patients and elevated IL6 and IL1B expression levels, suggesting that synovial inflammation might partly originate from pro-inflammatory cytokines in blood. Discussion: These findings offered new understanding of the molecular mechanisms underlying blood and synovium communication in OA, and provided potential therapeutic drug targets for OA treatment to simultaneously modulate systemic inflammation and local angiogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.